Documentos de Nguyen T.H. | REDI

Regresar

Mostrando 3 resultados de: 3

Filtros aplicados

Área de conocimiento: "Medicina interna"

Subtipo de publicación

Conference Object(1)

Publisher

International Journal of Stroke(2)

Área temáticas

Farmacología y terapéutica(2)

Medicina y salud(2)

Contabilidad(1)

Enfermedades(1)

Fisiología humana(1)

Área de conocimiento

Año de Publicación

Origen

Palabras Claves

Hypertension(2)

thrombolysis(2)

Acute ischaemic stroke(1)

Brain Infarction(1)

Applicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous thrombolysis in England and Wales: Comparison with the Sentinel Stroke National Audit Programme registry

Abstract: Background: Randomized controlled trials provide high-level evidence, but the necessity to include s

Palabras claves:

acute ischemic stroke, Alteplase, Clinical trial, health outcomes, thrombolysis

Arima H., Bath P.M.W., Bray B.D., Broderick J.P., Chalmers J., Durham A.C., Kim J.S., Lavados P.M., Lee T.H., Martins S.O., Nguyen T.H., Octavio Marques Pontes-Neto, Paley L., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., Rudd A.G., S Anderson C., Sharma V.K., Sprigg N., Wang J.G., Wang X., Woodward M.

Low-Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy the ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study)

Conference Object

Abstract: Background and Purpose'Many patients receiving thrombolysis for acute ischemic stroke are on prior a

Palabras claves:

aspirin, Brain Infarction, Hypertension, intracranial hemorrhages, Tissue plasminogen activator

Arima H., Bath P.M.W., Billot L., Broderick J.P., Chalmers J., Demchuk A.M., Donnan G.A., Kim J.S., Lavados P.M., Lee T.H., Lindley R.I., Martins S.O., Nguyen T.H., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., S Anderson C., Sato S., Sharma V.K., Wang J.G., Wang X., Woodward M.

Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2×2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment

Abstract: Rationale: Controversy exists over the optimal dose of intravenous (iv) recombinant tissue plasminog

Palabras claves:

Acute ischaemic stroke, Alteplase, Dose, Hypertension, Rt-PA, thrombolysis

Arima H., Bath P.M.W., Broderick J.P., Chalmers J., Chen X., Demchuk A.M., Donnan G.A., Fuentes S., Huang Y., Kim J.S., Lavados P.M., Lee T.H., Levi C., Lindley R.I., Martins S.O., Nguyen T.H., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., S Anderson C., Sharma V.K., Silva-Sieger F.A., Stapf C., Wang J.G., Woodward M.